These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

143 related items for PubMed ID: 4616624

  • 21. Proteases of Clostridium botulinum. 3. Isolation and characterization of proteases from Clostridium botulinum types A,B,C,D and F.
    Tjaberg TB.
    Acta Vet Scand; 1973; 14(4):538-59. PubMed ID: 4585531
    [No Abstract] [Full Text] [Related]

  • 22. Repression of toxin production by tryptophan in Clostridium botulinum type E.
    Leyer GJ, Johnson EA.
    Arch Microbiol; 1990; 154(5):443-7. PubMed ID: 2256780
    [Abstract] [Full Text] [Related]

  • 23. Activation of botulinum toxins in the absence of nicking.
    Ohishi I, Sakaguchi G.
    Infect Immun; 1977 Aug; 17(2):402-7. PubMed ID: 19360
    [Abstract] [Full Text] [Related]

  • 24. Nicking of single chain Clostridium botulinum type A neurotoxin by an endogenous protease.
    Dekleva ML, DasGupta BR.
    Biochem Biophys Res Commun; 1989 Jul 31; 162(2):767-72. PubMed ID: 2667520
    [Abstract] [Full Text] [Related]

  • 25. Production of trypsin-activable toxic components by Clostridium botulinum types C and D [proceedings].
    Nakane A, Oguma K, Shiozaki M, Iida H.
    Jpn J Med Sci Biol; 1978 Apr 31; 31(2):166-9. PubMed ID: 355684
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Proteases of Clostridium botulinum. IV. Inhibitors against proteases from Clostridium botulinum.
    Tjaberg TB, Fossum K.
    Acta Vet Scand; 1973 Apr 31; 14(4):560-9. PubMed ID: 4202008
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. [Ultrastructure of Clostridium botulinum type E during the process of toxin formation].
    Lysenko AI, Cherniavskiĭ VI, Kulakova GS, Iskritskiĭ GV.
    Mikrobiol Zh; 1973 Apr 31; 35(3):308-12. PubMed ID: 4598684
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Partial characterization of the enzymatic activity associated with the binary toxin (type C2) produced by Clostridium botulinum.
    Simpson LL, Zepeda H, Ohishi I.
    Infect Immun; 1988 Jan 31; 56(1):24-7. PubMed ID: 3121511
    [Abstract] [Full Text] [Related]

  • 34. Proteases of Clostridium botulinum. V. Studies on the serological relationship between proteases from Clostridium botulinum and other spore-forming bacteria.
    Tjaberg TB, Fossum K.
    Acta Vet Scand; 1973 May 31; 14(5):700-11. PubMed ID: 4359093
    [Abstract] [Full Text] [Related]

  • 35. Camelid single domain antibodies (VHHs) as neuronal cell intrabody binding agents and inhibitors of Clostridium botulinum neurotoxin (BoNT) proteases.
    Tremblay JM, Kuo CL, Abeijon C, Sepulveda J, Oyler G, Hu X, Jin MM, Shoemaker CB.
    Toxicon; 2010 Nov 31; 56(6):990-8. PubMed ID: 20637220
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Toxin production by Clostridium botulinum in grass.
    Notermans S, Kozaki S, van Schothorst M.
    Appl Environ Microbiol; 1979 Nov 31; 38(5):767-71. PubMed ID: 44443
    [Abstract] [Full Text] [Related]

  • 40. Aerobic growth and toxigenicity of Clostridium botulinum types A and B.
    Dezfulian M.
    Folia Microbiol (Praha); 1999 Nov 31; 44(2):167-70. PubMed ID: 10588051
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.